Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05GPK
|
||||
| Former ID |
DNC013838
|
||||
| Drug Name |
Biphenyl-3-ylboronic acid
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529790] | ||
| Formula |
C12H11BO2
|
||||
| Canonical SMILES |
B(C1=CC(=CC=C1)C2=CC=CC=C2)(O)O
|
||||
| InChI |
1S/C12H11BO2/c14-13(15)12-8-4-7-11(9-12)10-5-2-1-3-6-10/h1-9,14-15H
|
||||
| InChIKey |
GOXICVKOZJFRMB-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529790] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||